#United States #Philadelphia #Securities Fraud #Berger Montague #Hims & Hers

Berger Montague Investigates Hims & Hers Health Inc.

On July 1, 2025, Berger Montague, a well-regarded national securities litigation law firm, announced its investigation into potential securities fraud claims against Hims & Hers Health Inc. (ticker: HIMS). This inquiry centers around whether the company violated federal security laws by issuing false or misleading statements to its investors during a defined period from April 29, 2025 to June 22, 2025, referred to as the “Class Period.”

Background of the Investigation

The investigation follows a significant event that occurred on June 23, 2025, when Hims & Hers faced a dramatic decline in stock value—dropping over 34%. This stock plunge can be attributed to the termination of a partnership with Novo Nordisk, reportedly due to Hims & Hers' unauthorized marketing and sales of compounded semaglutide drugs. This incident has led to the filing of a complaint against the firm, raising allegations of material misstatements and omissions, which some investors believe represent a violation of federal securities laws.

Opportunity for Investors

It’s crucial for investors involved with Hims & Hers to act promptly. Those who are interested in having their voices heard as part of the class action lawsuit must apply to be lead plaintiffs by August 25, 2025. The role of a lead plaintiff is vital, as they guide the proceedings and advocate for the collective interests of harmed investors.

If you currently hold shares in Hims & Hers and wish to understand more about these ongoing legal actions, you are encouraged to reach out to Berger Montague directly. Interested parties can contact Andrew Abramowitz at [email protected] or call (215) 875-3015, or get in touch with Caitlin Adorni at [email protected] or (267)764-4865 for further information.

About Berger Montague

Founded in 1970, Burger Montague is recognized for its leadership in securities class action litigation. With offices in major cities like Philadelphia, Minneapolis, and San Francisco, they have been steadfast in their commitment to represent both individual and institutional investors for over fifty years. Berger Montague's expertise is not limited to just securities fraud but encompasses a broad spectrum of litigation matters within the financial realm.

The firm remains dedicated to ensuring that investors are informed of their rights and avenues for recourse following incidents of potential fraud.

As this investigation unfolds, it stands as a reminder of the responsibilities that public companies have in communicating transparently with their investors. The legal landscape surrounding securities fraud is complex, and firms like Berger Montague play a crucial role in navigating these challenges for investors nationwide.